In a move to gain access to early stage innovation, Johnson & Johnson (NYSE:JNJ) is opening innovation centers in Europe and China as well as in Boston. Earlier this year, its Janssen pharmaceuticals division opened an innovation center within the company’s West Coast Research Center in San Diego.
The centers will be staffed with J&J science and technology experts from the community who will identify early stage innovations and establish collaborations to invest in and speed development of those concepts to solve unmet needs in patients, a company statement said. Areas of potential collaboration include pharmaceutical, medical device and diagnostics, and consumer companies.
The centers will have the flexibility to adapt deal structures to match the early stage opportunity, the statement said. A J&J spokeswoman told MedCity News that the company would enlist “a variety of creative types of deal-making.” The focus is on assets with a strategic fit, she said. It will be working with academic researchers and emerging startup companies.
To read the full, original article click on this link: J&J to open innovation centers in London, China, U.S. to hunt for novel, early stage deals | MedCity News
